38th Annual Immunohematology & Blood Transfusion Symposium
A record breaking number of people came to the 38th Annual Immunohematology & Blood Transfusion Symposium Sept. 19 in the NIH Clinical Center. The audience heard presentations that educated participants about transfusion medicine practices and guidelines in Europe and global awareness of blood availability and safety worldwide. Esteemed presenters from the U.S. Food and Drug Administration, the American Red Cross, Johns Hopkins University School of Medicine, and the National Institutes of Health discussed continuing transfusion medicine advancements and persistent concerns. The day ended with a presentation by Dr. John Tisdale, from the National Heart, Lung, and Blood Institute, entitled "Curative Therapies for Hemoglobinopathies."
9th Annual Red Cell Genotyping Patient First Symposium
The 9th Annual Red Cell Genotyping Patient First Symposium's keynote address was given by Dr. Michael F. Murphy, who is the current president of the professional organization, the AABB. This was the beginning of an impressive line-up of speakers to inform the audience of the latest technologies, applications, and values of red blood cell genotyping when applied to patient care and monitoring.
AABB's recipient of the Karl Landsteiner Award, Dr. Fumiichiro Yamamoto, gave the last presentation entitled "How is all began in the 1980's: MN, ABO and Rh, and where we stand today." His talk left the audience with a good understand of discovery and areas to consider for moving into the future.
